NeuroSense Therapeutics (NRSN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.07, -3.15% vs the prior close of $3.17.
- Volume 9.70K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NRSN slides 3.2% to $3.07. Closed at $3.07, -3.15% vs the prior close of $3.17. Day range $3.06–$3.19, opened at $3.06.
NRSN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NRSN slides 3.2% to $3.07
- Closed at $3.07, -3.15% vs the prior close of $3.17. Day range $3.06–$3.19, opened at $3.06.
- Volume was 9.70K shares, 0.4x its 50-day average of 22.89K — lighter than usual.
- Price is -54.3% vs its 50-day average ($6.72) and -77.6% vs its 200-day average ($13.68).
- 52-week range $2.87–$26.64; today's close sits at 1% of that range, 88.5% below the 52-week high.
Oct 15, 2026 — NRSN jumps 3.6% to $3.17
- Closed at $3.17, +3.59% vs the prior close of $3.06. Day range $2.87–$3.26, opened at $3.08.
- Volume was 11.80K shares, 0.5x its 50-day average of 22.94K — lighter than usual.
- Price is -53.8% vs its 50-day average ($6.86) and -76.9% vs its 200-day average ($13.74).
- 52-week range $2.87–$26.64; today's close sits at 1% of that range, 88.1% below the 52-week high.
Oct 14, 2026 — NRSN slides 12.3% to $3.06, a 52-week low
- Closed at $3.06, -12.32% vs the prior close of $3.49. Day range $3.05–$3.60, opened at $3.56.
- Volume was 30.80K shares, 1.4x its 50-day average of 22.48K.
- Price is -56.4% vs its 50-day average ($7.01) and -77.8% vs its 200-day average ($13.80).
- 52-week range $3.05–$26.64; today's close sits at 0% of that range, 88.5% below the 52-week high.
Oct 13, 2026 — NRSN ends flat (+0.3%) to $3.49 on 1.9x normal volume
- Closed at $3.49, +0.29% vs the prior close of $3.48. Day range $3.37–$3.78, opened at $3.77.
- Volume was 42.90K shares, 1.9x its 50-day average of 22.07K — unusually heavy trading.
- Price is -51.2% vs its 50-day average ($7.16) and -74.8% vs its 200-day average ($13.86).
- 52-week range $3.28–$26.64; today's close sits at 1% of that range, 86.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — NRSN slides 4.9% to $3.48, a 52-week low
- Closed at $3.48, -4.92% vs the prior close of $3.66. Day range $3.28–$3.66, opened at $3.66.
- Volume was 7.40K shares, 0.3x its 50-day average of 24.70K — lighter than usual.
- Price is -52.2% vs its 50-day average ($7.27) and -75.0% vs its 200-day average ($13.93).
- 52-week range $3.28–$26.64; today's close sits at 1% of that range, 86.9% below the 52-week high.
Oct 9, 2026 — NRSN rises 2.2% to $3.66
- Closed at $3.66, +2.23% vs the prior close of $3.58. Day range $3.61–$3.85, opened at $3.61.
- Volume was 15.60K shares, 0.6x its 50-day average of 24.54K.
- Price is -50.5% vs its 50-day average ($7.39) and -73.8% vs its 200-day average ($13.99).
- 52-week range $3.56–$26.64; today's close sits at 0% of that range, 86.3% below the 52-week high.
Oct 8, 2026 — NRSN slides 6.3% to $3.58, a 52-week low
- Closed at $3.58, -6.28% vs the prior close of $3.82. Day range $3.56–$3.90, opened at $3.82.
- Volume was 15.80K shares, 0.6x its 50-day average of 25.26K.
- Price is -52.3% vs its 50-day average ($7.51) and -74.5% vs its 200-day average ($14.06).
- 52-week range $3.56–$26.64; today's close sits at 0% of that range, 86.6% below the 52-week high.
Oct 7, 2026 — NRSN slides 6.1% to $3.82, a 52-week low
- Closed at $3.82, -6.14% vs the prior close of $4.07. Day range $3.79–$4.07, opened at $3.95.
- Volume was 12.80K shares, 0.5x its 50-day average of 25.51K — lighter than usual.
- Price is -49.9% vs its 50-day average ($7.63) and -73.0% vs its 200-day average ($14.12).
- 52-week range $3.79–$26.64; today's close sits at 0% of that range, 85.7% below the 52-week high.
Oct 6, 2026 — NRSN rises 1.0% to $4.07
- Closed at $4.07, +0.99% vs the prior close of $4.03. Day range $3.94–$4.33, opened at $4.03.
- Volume was 17.80K shares, 0.7x its 50-day average of 25.24K.
- Price is -47.7% vs its 50-day average ($7.78) and -71.3% vs its 200-day average ($14.19).
- 52-week range $3.82–$26.64; today's close sits at 1% of that range, 84.7% below the 52-week high.
Oct 5, 2026 — NRSN rises 2.4% to $4.03
- Closed at $4.03, +2.41% vs the prior close of $3.93. Day range $3.96–$4.54, opened at $4.06.
- Volume was 12.20K shares, 0.5x its 50-day average of 25.15K — lighter than usual.
- Price is -49.2% vs its 50-day average ($7.93) and -71.7% vs its 200-day average ($14.25).
- 52-week range $3.82–$26.64; today's close sits at 1% of that range, 84.9% below the 52-week high.
Oct 2, 2026 — NRSN dips 2.8% to $3.93, a 52-week low, 7 down days in a row
- Closed at $3.93, -2.84% vs the prior close of $4.05. Day range $3.82–$4.01, opened at $3.97.
- Volume was 24.10K shares, 1.0x its 50-day average of 24.88K.
- Price is -51.4% vs its 50-day average ($8.09) and -72.5% vs its 200-day average ($14.31).
- 52-week range $3.82–$26.64; today's close sits at 1% of that range, 85.2% below the 52-week high.
- That makes 7 straight losses.
- SEC filings that day: 6-K.
NRSN latest news & SEC filings
Every SEC filing by or about NRSN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade NRSN
- How much it moves: over the last 20 sessions the average daily move was 5.79% (largest 26.6%). That is a volatile stock.
- Liquidity: about 22.50K shares (≈$69.06K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.07 vs a range of $2.87–$26.64 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Sep 14, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Or Eisenberg bought 250,000 shares on Jun 16, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Oct 2, 2026; 6-K Sep 25, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NRSN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.06 | 3.19 | 3.06 | 3.07 | 9.70K |
| Oct 15, 2026 | 3.08 | 3.26 | 2.87 | 3.17 | 11.80K |
| Oct 14, 2026 | 3.56 | 3.60 | 3.05 | 3.06 | 30.80K |
| Oct 13, 2026 | 3.77 | 3.78 | 3.37 | 3.49 | 42.90K |
| Oct 12, 2026 | 3.66 | 3.66 | 3.28 | 3.48 | 7.40K |
| Oct 9, 2026 | 3.61 | 3.85 | 3.61 | 3.66 | 15.60K |
| Oct 8, 2026 | 3.82 | 3.90 | 3.56 | 3.58 | 15.80K |
| Oct 7, 2026 | 3.95 | 4.07 | 3.79 | 3.82 | 12.80K |
| Oct 6, 2026 | 4.03 | 4.33 | 3.94 | 4.07 | 17.80K |
| Oct 5, 2026 | 4.06 | 4.54 | 3.96 | 4.03 | 12.20K |
| Oct 2, 2026 | 3.97 | 4.01 | 3.82 | 3.93 | 24.10K |
| Oct 1, 2026 | 4.37 | 4.37 | 3.83 | 4.05 | 50.10K |
| Sep 30, 2026 | 4.71 | 4.74 | 4.00 | 4.43 | 40.40K |
| Sep 29, 2026 | 5.04 | 5.54 | 4.36 | 4.78 | 35.80K |
| Sep 28, 2026 | 6.91 | 7.15 | 4.93 | 5.10 | 61.50K |
| Sep 25, 2026 | 7.18 | 7.18 | 6.73 | 6.95 | 8.60K |
| Sep 24, 2026 | 7.20 | 7.40 | 6.93 | 7.40 | 8.90K |
| Sep 23, 2026 | 7.35 | 7.40 | 6.80 | 7.40 | 8.80K |
| Sep 22, 2026 | 6.70 | 7.41 | 6.70 | 7.18 | 28.50K |
| Sep 21, 2026 | 6.42 | 6.85 | 6.40 | 6.62 | 6.40K |
About NeuroSense Therapeutics
NeuroSense Therapeutics (NRSN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HERZLIYA, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1875091.
NRSN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Cary J Claiborne | Director | Mar 18, 2026 |
| Roy Golan | Director | Mar 18, 2026 |
| Mark Leuchtenberger | Director | Mar 18, 2026 |
| Revital Mandil-Levin | Director | Mar 31, 2026 |
| Christine A Pellizzari | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alon Ben-Noon | Chief Executive Officer | Jun 17, 2026 |
| Hagit Binder | General Manager | Mar 30, 2026 |
| Or Eisenberg | Chief Financial Officer | Jun 17, 2026 |
| Niva Russek-Blum | Chief Technology Officer | Mar 30, 2026 |
| Ferenc Tracik | Chief Medical Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 16, 2026 | Or Eisenberg | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Or Eisenberg | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Or Eisenberg | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Or Eisenberg | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Alon Ben-Noon | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Alon Ben-Noon | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Alon Ben-Noon | Buy | 250,000 | $0.80 |
| Jun 16, 2026 | Alon Ben-Noon | Buy | 250,000 | $0.80 |
NRSN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NRSN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NRSN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.